상세정보
Export to Refworks부가기능
The Real Option Value of Life And Innovation
상세 프로파일
| 자료유형 | 학위논문 |
|---|---|
| 서명/저자사항 | The Real Option Value of Life And Innovation. |
| 개인저자 | Li, Meng. |
| 단체저자명 | University of Washington. Pharmacy. |
| 발행사항 | [S.l.]: University of Washington., 2018. |
| 발행사항 | Ann Arbor: ProQuest Dissertations & Theses, 2018. |
| 형태사항 | 99 p. |
| 기본자료 저록 | Dissertation Abstracts International 79-12B(E). Dissertation Abstract International |
| ISBN | 9780438176782 |
| 학위논문주기 | Thesis (Ph.D.)--University of Washington, 2018. |
| 일반주기 |
Source: Dissertation Abstracts International, Volume: 79-12(E), Section: B.
Adviser: Louis Garrison. |
| 요약 | Background: Recent developments in healthcare value assessments have expanded the definition of value for medical technologies. The option value of a life-extending treatment is the opportunity of benefiting from future innovations during the ex |
| 요약 | Methods: In the first study, an interrupted time series analysis was conducted using a large administrative claims database to test whether the utilization of existing treatments changed after the disclosures of the then-investigational drug ipi |
| 요약 | Results: In the first study, 1,846 metastatic melanoma patients were included. After adjusting for clinical and sociodemographic variables, as well as the underlying time trend, the disclosure of ipilimumab's phase II result was associated with |
| 요약 | Conclusion: This dissertation research provided the first empirical evidence of the impact of real option value in cancer treatment decision-making. It was also the first to incorporate option value in an ex ante CEA and estimated its potential |
| 일반주제명 | Pharmaceutical sciences. |
| 언어 | 영어 |
| 바로가기 | 
: 이 자료의 원문은 한국교육학술정보원에서 제공합니다. |
